Jazz Pharmaceuticals plc (J7Z) — Net Asset Quality Index
Jazz Pharmaceuticals plc (J7Z) has a Net Asset Quality Index of 38.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €11.86 Billion minus total liabilities of €7.33 Billion yields net assets of €4.53 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Jazz Pharmaceuticals plc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jazz Pharmaceuticals plc Net Asset Quality Index Over Time (2013–2025)
This chart shows how Jazz Pharmaceuticals plc's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 38.2%, representing net assets of €4.53 Billion against total assets of €11.86 Billion EUR. Explore Jazz Pharmaceuticals plc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Jazz Pharmaceuticals plc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Jazz Pharmaceuticals plc from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see J7Z stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.0% | €4.32 Billion | €11.66 Billion | €7.34 Billion | ▲ +3.0 pp |
| 2024 | 34.1% | €4.09 Billion | €12.01 Billion | €7.92 Billion | ▲ +1.3 pp |
| 2023 | 32.8% | €3.74 Billion | €11.39 Billion | €7.66 Billion | ▲ +4.3 pp |
| 2022 | 28.5% | €3.09 Billion | €10.84 Billion | €7.75 Billion | ▼ -3.8 pp |
| 2021 | 32.2% | €3.97 Billion | €12.30 Billion | €8.33 Billion | ▼ -23.8 pp |
| 2020 | 56.0% | €3.66 Billion | €6.54 Billion | €2.88 Billion | ▼ -0.2 pp |
| 2019 | 56.2% | €3.11 Billion | €5.54 Billion | €2.43 Billion | ▲ +3.2 pp |
| 2018 | 53.0% | €2.76 Billion | €5.20 Billion | €2.45 Billion | ▲ +0.0 pp |
| 2017 | 53.0% | €2.71 Billion | €5.12 Billion | €2.41 Billion | ▲ +13.8 pp |
| 2016 | 39.1% | €1.88 Billion | €4.80 Billion | €2.92 Billion | ▼ -8.9 pp |
| 2015 | 48.0% | €1.60 Billion | €3.33 Billion | €1.73 Billion | ▲ +6.9 pp |
| 2014 | 41.1% | €1.37 Billion | €3.34 Billion | €1.97 Billion | ▼ -16.8 pp |
| 2013 | 57.9% | €1.30 Billion | €2.24 Billion | €942.69 Million | — |